Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir BE Study
PACTR201611001870300Not yet recruiting
- Sponsor
- Danadams Pharmaceutical
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tenofovir (2 arms), sponsored by Danadams Pharmaceutical. Primary endpoint: Bioequivalence of the two investigational products. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
tenofovir
Beyond the preview
Go deeper on PACTR201611001870300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201611001870300.